Literature DB >> 15304114

Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.

Chiao-Hsiung Chuang1, Bor-Shyang Sheu, Hsiao-Bai Yang, Ai-wen Kao, Hsiu-Chi Cheng, Wei-Jen Yao.   

Abstract

BACKGROUND AND AIM: Helicobacter pylori infection causes hypergastrinemia. This study aimed to determine the association between serum gastrin and the severity of H. pylori-related gastric histology.
METHODS: A total of 458 dyspeptic patients were included in this study after the absence of gastric malignancy was confirmed using endoscopy. The gastric specimens of each patient were collected from the antrum and corpus for the analysis of H. pylori-related histology changes by updated Sydney's system. Before endoscopy, the fasting blood samples were collected for gastrin analysis.
RESULTS: The H. pylori-infected patients had higher gastrin levels than those without infection (P = 0.01). Gastrin levels were related to H. pylori density and acute and chronic inflammation scores in the corpus mucosa (P < 0.05), but not in the antral mucosa (P = NS). Gastrin levels were also not related to the presence of gastric atrophy. Multivariate regression showed that the gastrin level was only related to acute corpus inflammation. However, in the patients without infection, the gastrin level was also associated with acute corpus inflammation. Nevertheless, the patients with denser H. pylori infection were more likely to have acute corpus gastritis than those with lighter H. pylori infection, and thus presented with higher gastrin levels (P < 0.05).
CONCLUSIONS: The increased level of gastrin of serum after H. pylori infection was associated with acute inflammation in the gastric corpus mucosa, but not in the antral mucosa. Denser H. pylori infection causes more severe corpus gastritis and thus may lead to a higher fasting level of gastrin of serum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304114     DOI: 10.1111/j.1440-1746.2004.03416.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

Review 1.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

Review 2.  The immune microenvironment in gastric adenocarcinoma.

Authors:  Yana Zavros; Juanita L Merchant
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-14       Impact factor: 73.082

Review 3.  Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.

Authors:  Helge L Waldum; Øyvind Hauso; Øystein F Sørdal; Reidar Fossmark
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

4.  Gastritis induced by Helicobacter pylori infection in experimental rats.

Authors:  Mohamed M Elseweidy; Mona M Taha; Nahla N Younis; Khadiga S Ibrahim; Hamdi A Hamouda; Mohamed A Eldosouky; Hala Soliman
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

5.  The regenerating gene iα is overexpressed in atrophic gastritis rats with hypergastrinemia.

Authors:  Shujie Chen; Jing Zhong; Qunyan Zhou; Xiaofeng Lu; Liangjing Wang; Jianmin Si
Journal:  Gastroenterol Res Pract       Date:  2011-09-22       Impact factor: 2.260

6.  Assessment of Gastric Acidity by Conventional Endoscopy With Serological Gastric Markers.

Authors:  Byung Chul Kim; Mi Ae Song; Sung Ho Kwon; Min Ji Kim
Journal:  Gastroenterology Res       Date:  2018-04-07

7.  Immunopathological and Modulatory Effects of Cag A+ Genotype on Gastric Mucosa, Inflammatory Response, Pepsinogens, and Gastrin-17 Secretion in Iraqi Patients infected with H. pylori.

Authors:  Ali Ibrahim Ali Al-Ezzy
Journal:  Open Access Maced J Med Sci       Date:  2018-05-14

8.  Gastric Hypersecretory States: Investigation and Management.

Authors:  Jennifer Phan; Jihane N Benhammou; Joseph R Pisegna
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.